Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors
- PMID: 11870260
- DOI: 10.1124/pr.54.1.43
Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors
Abstract
The release of transmitters at sympathoeffector junctions is not constant, but subject to modulation by a plethora of different mechanisms. In this respect, presynaptic receptors located on the sympathetic axon terminals are of utmost importance, because they are activated by exogenous agonists and by endogenous neurotransmitters. In the latter case, the transmitters that activate the presynaptic receptors of a nerve terminal may be released either from the very same nerve ending or from a different axon terminal, and the receptors involved are auto- and heteroreceptors, respectively. In terms of their structural and functional features, receptors of sympathetic axon terminals can be categorized as either ionotropic (transmitter-gated ion channels) or metabotropic (most commonly G protein-coupled) receptors. This review summarizes results on more than 30 different metabotropic and four different ionotropic receptors that have been found to control the amount of transmitter being released from sympathetic neurons. Each of these receptors may not only stimulate, facilitate, and reduce sympathetic transmitter release, respectively, but also interact with the functions of other receptors present on the same axonal varicosity. This provides a multitude of mechanisms that regulate the amount of sympathetic transmitter output. Accordingly, a sophisticated cross-talk within and between extra- and intracellular signals is integrated at axon terminals to adapt the strength of sympathoeffector transmission to a given situation. This will not only determine the function of the sympathetic nervous system in health and disease, but also therapeutic and untoward effects of drugs that bind to the presynaptic receptors in sympathetically innervated tissues.
Similar articles
-
Presynaptic lonotropic receptors.Handb Exp Pharmacol. 2008;(184):479-527. doi: 10.1007/978-3-540-74805-2_15. Handb Exp Pharmacol. 2008. PMID: 18064423 Review.
-
Receptors controlling transmitter release from sympathetic neurons in vitro.Prog Neurobiol. 1997 Feb;51(3):225-42. doi: 10.1016/s0301-0082(96)00056-1. Prog Neurobiol. 1997. PMID: 9089789 Review.
-
Modulation of transmitter release via presynaptic ligand-gated ion channels.Curr Mol Pharmacol. 2008 Jun;1(2):106-29. doi: 10.2174/1874467210801020106. Curr Mol Pharmacol. 2008. PMID: 20021427 Review.
-
ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors.J Neurosci. 1999 Jan 15;19(2):737-46. doi: 10.1523/JNEUROSCI.19-02-00737.1999. J Neurosci. 1999. PMID: 9880594 Free PMC article.
-
Human presynaptic receptors.Pharmacol Ther. 2017 Apr;172:1-21. doi: 10.1016/j.pharmthera.2016.11.005. Epub 2016 Nov 27. Pharmacol Ther. 2017. PMID: 27902931 Review.
Cited by
-
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.Naunyn Schmiedebergs Arch Pharmacol. 2012 Apr;385(4):385-96. doi: 10.1007/s00210-011-0717-8. Epub 2012 Jan 4. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22215206
-
LncRNA NONRATT021972 involved the pathophysiologic processes mediated by P2X7 receptors in stellate ganglia after myocardial ischemic injury.Purinergic Signal. 2016 Mar;12(1):127-37. doi: 10.1007/s11302-015-9486-z. Epub 2015 Dec 2. Purinergic Signal. 2016. PMID: 26630943 Free PMC article.
-
Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.Biomed Res Int. 2016;2016:2056786. doi: 10.1155/2016/2056786. Epub 2016 Dec 27. Biomed Res Int. 2016. PMID: 28116293 Free PMC article. Review.
-
Simultaneous parasympathetic and sympathetic activation reveals altered autonomic control of heart rate, vascular tension, and epinephrine release in anesthetized hypertensive rats.Front Neurol. 2011 Nov 23;2:71. doi: 10.3389/fneur.2011.00071. eCollection 2011. Front Neurol. 2011. PMID: 22131984 Free PMC article.
-
Impairment of exocytotic transmitter release by decynium-22 through an inhibition of ion channels.Front Pharmacol. 2023 Oct 10;14:1276100. doi: 10.3389/fphar.2023.1276100. eCollection 2023. Front Pharmacol. 2023. PMID: 37881182 Free PMC article.